{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:40:38Z","timestamp":1788381638656,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T00:00:00Z","timestamp":1547683200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s10120-019-00924-0","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T07:49:04Z","timestamp":1547711344000},"page":"705-722","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["MiR-6872 host gene SEMA3B and its antisense lncRNA SEMA3B-AS1 function synergistically to suppress gastric cardia adenocarcinoma progression"],"prefix":"10.1007","volume":"22","author":[{"given":"Wei","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoliang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supeng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,17]]},"reference":[{"key":"924_CR1","first-page":"1","volume":"182","author":"M Vial","year":"2010","unstructured":"Vial M, Grande L, Pera M. Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and uppergastric third. Recent Results Cancer Res. 2010;182:1\u201317.","journal-title":"Recent Results Cancer Res"},{"key":"924_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"924_CR3","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1001\/jama.1995.03530060048032","volume":"274","author":"WH Chow","year":"1995","unstructured":"Chow WH, Finkle WD, McLaughlin JK, Frankl H, Ziel HK, Fraumeni JF. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA. 1995;274:474\u20137.","journal-title":"JAMA"},{"key":"924_CR4","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3748\/wjg.v9.i6.1156","volume":"9","author":"LD Wang","year":"2003","unstructured":"Wang LD, Zheng S, Zheng ZY, Casson AG. Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. World J Gastroenterol. 2003;9:1156\u201364.","journal-title":"World J Gastroenterol"},{"key":"924_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/ijc.28999","volume":"136","author":"M Plummer","year":"2015","unstructured":"Plummer M, Franceschi S, Vignat J, Forman D, de Martel C. Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer. 2015;136:487\u201390.","journal-title":"Int J Cancer"},{"key":"924_CR6","first-page":"1949","volume":"60","author":"II Wistuba","year":"2000","unstructured":"Wistuba II, Behrens C, Virmani AK, Mele G, Milchgrub S, Girard L, et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic\/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res. 2000;60:1949\u201360.","journal-title":"Cancer Res"},{"key":"924_CR7","first-page":"6116","volume":"60","author":"MI Lerman","year":"2000","unstructured":"Lerman MI, Minna JD. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The international lung cancer chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res. 2000;60:6116\u201333.","journal-title":"Cancer Res"},{"key":"924_CR8","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1128\/JB.180.9.2345-2349.1998","volume":"180","author":"J Chen","year":"1998","unstructured":"Chen J, Brevet A, Blanquet S, Plateau P. Control of 5\u2032,5\u2032-dinucleoside triphosphate catabolism by APH1, a Saccharomyces cerevisiae analog of human FHIT. J Bacteriol. 1998;180:2345\u20139.","journal-title":"J Bacteriol"},{"key":"924_CR9","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1158\/1078-0432.CCR-07-0015","volume":"13","author":"W Yue","year":"2007","unstructured":"Yue W, Dacic S, Sun Q, Landreneau R, Guo M, Zhou W, et al. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation. Clin Cancer Res. 2007;13:4336\u201344.","journal-title":"Clin Cancer Res"},{"key":"924_CR10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1080\/07357900802620828","volume":"27","author":"W Guo","year":"2009","unstructured":"Guo W, Dong Z, Chen Z, Yang Z, Wen D, Kuang G, et al. Aberrant CpG Island hypermethylation of RASSF1A in gastric cardia adenocarcinoma. Cancer Invest. 2009;27:459\u201365.","journal-title":"Cancer Invest"},{"key":"924_CR11","doi-asserted-by":"publisher","first-page":"e0123369","DOI":"10.1371\/journal.pone.0123369","volume":"10","author":"VI Loginov","year":"2015","unstructured":"Loginov VI, Dmitriev AA, Senchenko VN, Pronina IV, Khodyrev DS, Kudryavtseva AV, et al. Tumor suppressor function of the SEMA3B Gene in human lung and renal cancers. PLoS One. 2015;10:e0123369.","journal-title":"PLoS One"},{"key":"924_CR12","doi-asserted-by":"publisher","DOI":"10.4238\/gmr.15017664","author":"CH Pang","year":"2016","unstructured":"Pang CH, Du W, Long J, Song LJ. Mechanism of SEMA3B gene silencing and clinical significance in glioma. Genet Mol Res. 2016. \n                    https:\/\/doi.org\/10.4238\/gmr.15017664\n                    \n                  .","journal-title":"Genet Mol Res"},{"key":"924_CR13","doi-asserted-by":"publisher","first-page":"8295","DOI":"10.1158\/0008-5472.CAN-07-6601","volume":"68","author":"E Castro-Rivera","year":"2008","unstructured":"Castro-Rivera E, Ran S, Brekken RA, Minna JD. Semaphorin 3B inhibits the phosphatidylinositol 3-kinase\/Akt pathway through neuropilin-1 in lung and breast cancer cells. Cancer Res. 2008;68:8295\u2013303.","journal-title":"Cancer Res"},{"key":"924_CR14","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3892\/or.2014.2972","volume":"31","author":"R Chen","year":"2014","unstructured":"Chen R, Zhuge X, Huang Z, Lu D, Ye X, Chen C, et al. Analysis of SEMA3B methylation and expression patterns in gastric cancer tissue and cell lines. Oncol Rep. 2014;31:1211\u20138.","journal-title":"Oncol Rep"},{"key":"924_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.canlet.2006.09.019","volume":"250","author":"E Riquelme","year":"2007","unstructured":"Riquelme E, Tang M, Baez S, Diaz A, Pruyas M, Wistuba II, et al. Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma. Cancer Lett. 2007;250:100\u20136.","journal-title":"Cancer Lett"},{"key":"924_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0092-8674(93)80064-L","volume":"75","author":"Y Luo","year":"1993","unstructured":"Luo Y, Raible D, Raper JA. Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell. 1993;75:217\u201327.","journal-title":"Cell"},{"key":"924_CR17","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1158\/1078-0432.CCR-09-1810","volume":"15","author":"P Gaur","year":"2009","unstructured":"Gaur P, Bielenberg DR, Samuel S, Bose D, Zhou Y, Gray MJ, et al. Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis. Clin Cancer Res. 2009;15:6763\u201370.","journal-title":"Clin Cancer Res"},{"key":"924_CR18","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/ijc.21090","volume":"116","author":"HJ Grote","year":"2005","unstructured":"Grote HJ, Schmiemann V, Geddert H, Rohr UP, Kappes R, Gabbert HE, et al. Aberrant promoter methylation of p16(INK4a), RARB2 and SEMA3B in bronchial aspirates from patients with suspected lung cancer. Int J Cancer. 2005;116:720\u20135.","journal-title":"Int J Cancer"},{"key":"924_CR19","first-page":"3352","volume":"63","author":"T Kuroki","year":"2003","unstructured":"Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Williams NN, et al. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer. Cancer Res. 2003;63:3352\u20135.","journal-title":"Cancer Res"},{"key":"924_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.canlet.2004.10.041","volume":"225","author":"M Ito","year":"2005","unstructured":"Ito M, Ito G, Kondo M, Uchiyama M, Fukui T, Mori S, et al. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer. Cancer Lett. 2005;225:131\u20139.","journal-title":"Cancer Lett"},{"key":"924_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281\u201397.","journal-title":"Cell"},{"key":"924_CR22","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/iub.1079","volume":"64","author":"X Gao","year":"2012","unstructured":"Gao X, Qiao Y, Han D, Zhang Y, Ma N. Enemy or partner: relationship between intronic micrornas and their host genes. IUBMB Life. 2012;64:835\u201340.","journal-title":"IUBMB Life"},{"key":"924_CR23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/path.2638","volume":"220","author":"RJ Taft","year":"2010","unstructured":"Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS. Non-coding RNAs: regulators of disease. J Pathol. 2010;220:126\u201339.","journal-title":"J Pathol"},{"key":"924_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ng.3192","volume":"47","author":"MK Iyer","year":"2015","unstructured":"Iyer MK, Niknafs YS, Malik R, Singhal U, Sahu A, Hosono Y, et al. The landscape of long noncoding RNAs in the human transcriptome. Nat Genet. 2015;47:199\u2013208.","journal-title":"Nat Genet"},{"key":"924_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"AM Schmitt","year":"2016","unstructured":"Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29:452\u201363.","journal-title":"Cancer Cell"},{"key":"924_CR26","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.1038\/ncomms7370","volume":"6","author":"V Amin","year":"2015","unstructured":"Amin V, Harris RA, Onuchic V, Jackson AR, Charnecki T, Paithankar S, et al. Epigenomic footprints across 111 reference epigenomes reveal tissue-specific epigenetic regulation of lincRNAs. Nat Commun. 2015;6:6370.","journal-title":"Nat Commun"},{"key":"924_CR27","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.ccell.2018.03.006","volume":"33","author":"Z Wang","year":"2018","unstructured":"Wang Z, Yang B, Zhang M, Guo W, Wu Z, Wang Y, et al. LncRNA epigenetic landscape analysis identifies EPIC1 as an oncogenic lncRNA that interacts with MYC and promotes cell-cycle progression in cancer. Cancer Cell. 2018;33:706\u201320.","journal-title":"Cancer Cell"},{"key":"924_CR28","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1046\/j.1365-2168.1998.00940.x","volume":"85","author":"JR Siewert","year":"1998","unstructured":"Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg. 1998;85:1457\u20139.","journal-title":"Br J Surg"},{"key":"924_CR29","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"924_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ng1521","volume":"37","author":"L Yu","year":"2005","unstructured":"Yu L, Liu C, Vandeusen J, Becknell B, Dai Z, Wu YZ, et al. Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nat Genet. 2005;37:265\u201374.","journal-title":"Nat Genet"},{"key":"924_CR31","first-page":"1088","volume":"43","author":"VI Loginov","year":"2009","unstructured":"Loginov VI, Khodyrev DS, Pronina IV, Maliukova AV, Kazubskaia TP, Ermilova VD, et al. Two CpG-islands of SEMA3B gene: methylation in clear cell renal cell carcinoma. Mol Biol (Mosk). 2009;43:1088\u201392.","journal-title":"Mol Biol (Mosk)"},{"key":"924_CR32","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.molcel.2018.04.028","volume":"70","author":"SS Dhar","year":"2018","unstructured":"Dhar SS, Zhao D, Lin T, Gu B, Pal K, Wu SJ, et al. MLL4 Is Required to Maintain Broad H3K4me3 Peaks and Super-Enhancers at Tumor Suppressor Genes. Mol Cell. 2018;70:825\u201341.","journal-title":"Mol Cell"},{"key":"924_CR33","doi-asserted-by":"publisher","first-page":"G771","DOI":"10.1152\/ajpgi.00499.2010","volume":"300","author":"M Ananthanarayanan","year":"2011","unstructured":"Ananthanarayanan M, Li Y, Surapureddi S, Balasubramaniyan N, Ahn J, Goldstein JA, et al. Histone H3K4 trimethylation by MLL3 as part of ASCOM complex is critical for NR activation of bile acid transporter genes and is downregulated in cholestasis. Am J Physiol Gastrointest Liver Physiol. 2011;300:G771\u201381.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"924_CR34","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/nrc2404","volume":"8","author":"G Neufeld","year":"2008","unstructured":"Neufeld G, Kessler O. The semaphorins: versatile regulators of tumour progression and tumour angiogenesis. Nat Rev Cancer. 2008;8:632\u201345.","journal-title":"Nat Rev Cancer"},{"key":"924_CR35","first-page":"542","volume":"62","author":"C Tse","year":"2002","unstructured":"Tse C, Xiang RH, Bracht T, Naylor SL. Human Semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line. Cancer Res. 2002;62:542\u20136.","journal-title":"Cancer Res"},{"key":"924_CR36","doi-asserted-by":"publisher","first-page":"D140","DOI":"10.1093\/nar\/gkj112","volume":"34","author":"S Griffiths-Jones","year":"2006","unstructured":"Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006;34:D140\u20134.","journal-title":"Nucleic Acids Res"},{"key":"924_CR37","doi-asserted-by":"publisher","first-page":"e13798","DOI":"10.1371\/journal.pone.0013798","volume":"5","author":"G Wang","year":"2010","unstructured":"Wang G, Wang Y, Shen C, Huang YW, Huang K, Huang TH, et al. RNA polymerase II binding patterns reveal genomic regions involved in microRNA gene regulation. PLoS One. 2010;5:e13798.","journal-title":"PLoS One"},{"key":"924_CR38","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1261\/rna.7240905","volume":"11","author":"S Baskerville","year":"2005","unstructured":"Baskerville S, Bartel DP. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA. 2005;11:241\u20137.","journal-title":"RNA"},{"key":"924_CR39","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.canlet.2018.01.053","volume":"419","author":"DH Bach","year":"2018","unstructured":"Bach DH, Lee SK. Long noncoding RNAs in cancer cells. Cancer Lett. 2018;419:152\u201366.","journal-title":"Cancer Lett"},{"key":"924_CR40","doi-asserted-by":"publisher","first-page":"12813","DOI":"10.1007\/s13277-016-5239-z","volume":"37","author":"S Wei","year":"2016","unstructured":"Wei S, Wang L, Zhang L, Li B, Li Z, Zhang Q, et al. ZNF143 enhances metastasis of gastric cancer by promoting the process of EMT through PI3K\/AKT signaling pathway. Tumour Biol. 2016;37:12813\u201321.","journal-title":"Tumour Biol"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10120-019-00924-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-019-00924-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-019-00924-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T01:02:58Z","timestamp":1579222978000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10120-019-00924-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,17]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["924"],"URL":"https:\/\/doi.org\/10.1007\/s10120-019-00924-0","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,17]]},"assertion":[{"value":"1 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Committee of the Fourth Hospital, Hebei Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}